{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:04:07Z","timestamp":1792242247958,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ecl.2021.08.005","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T15:50:13Z","timestamp":1636559413000},"page":"729-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Vitamin D\u2013dependent Hypercalcemia"],"prefix":"10.1016","volume":"50","author":[{"given":"Karl Peter","family":"Schlingmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2021.08.005_bib1","series-title":"Vitamin D","first-page":"13","article-title":"Photobiology of Vitamin D","author":"Holick","year":"2011"},{"issue":"4","key":"10.1016\/j.ecl.2021.08.005_bib2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","article-title":"Current understanding of the molecular actions of vitamin D","volume":"78","author":"Jones","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ecl.2021.08.005_bib3","series-title":"Vitamin D","first-page":"57","article-title":"The Vitamin D Binding Protein DBP","author":"Bouillon","year":"2011"},{"issue":"12","key":"10.1016\/j.ecl.2021.08.005_bib4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tibs.2004.10.005","article-title":"Enzymes involved in the activation and inactivation of vitamin D","volume":"29","author":"Prosser","year":"2004","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"10.1016\/j.ecl.2021.08.005_bib5","first-page":"2211","article-title":"Vitamin D: the vitamin and the hormone","volume":"33","author":"DeLuca","year":"1974","journal-title":"Fed Proc"},{"issue":"10","key":"10.1016\/j.ecl.2021.08.005_bib6","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1359\/jbmr.1997.12.10.1552","article-title":"The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus","volume":"12","author":"St-Arnaud","year":"1997","journal-title":"J\u00a0Bone Miner Res"},{"issue":"16","key":"10.1016\/j.ecl.2021.08.005_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM197310182891601","article-title":"Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D","volume":"289","author":"Fraser","year":"1973","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.ecl.2021.08.005_bib8","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1073\/pnas.131029498","article-title":"Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction","volume":"98","author":"Panda","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"7","key":"10.1016\/j.ecl.2021.08.005_bib9","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1210\/endo.142.7.8281","article-title":"Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets","volume":"142","author":"Dardenne","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ecl.2021.08.005_bib10","series-title":"Vitamin D","first-page":"777","article-title":"Extrarenal 1\u03b1-hydroxylase","author":"Hewison","year":"2011"},{"issue":"5","key":"10.1016\/j.ecl.2021.08.005_bib11","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI111147","article-title":"Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis","volume":"72","author":"Adams","year":"1983","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/bj2620173","article-title":"Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation","volume":"262","author":"Makin","year":"1989","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.ecl.2021.08.005_bib13","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/bi00430a051","article-title":"Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway","volume":"28","author":"Reddy","year":"1989","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.abb.2011.11.003","article-title":"25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D","volume":"523","author":"Jones","year":"2011","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"10.1016\/j.ecl.2021.08.005_bib15","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1210\/endo.141.7.7579","article-title":"Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D","volume":"141","author":"St-Arnaud","year":"2000","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ecl.2021.08.005_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ecl.2021.08.005_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3168\/jds.S0022-0302(82)82263-7","article-title":"Vitamin D3 toxicity in dairy cows","volume":"65","author":"Littledike","year":"1982","journal-title":"J\u00a0Dairy Sci"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0003-9861(80)90404-X","article-title":"Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes","volume":"202","author":"Shephard","year":"1980","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.abb.2010.10.012","article-title":"1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D","volume":"505","author":"Deluca","year":"2011","journal-title":"Arch Biochem Biophys"},{"issue":"654","key":"10.1016\/j.ecl.2021.08.005_bib20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/pgmj.55.650.897","article-title":"A\u00a0family with massive acute vitamin D intoxication","volume":"55","author":"Down","year":"1979","journal-title":"Postgrad Med J"},{"issue":"3","key":"10.1016\/j.ecl.2021.08.005_bib21","first-page":"225","article-title":"[Circulating metabolites of vitamin D in 14 children with hypercalcemia]","volume":"42","author":"Jacqz","year":"1985","journal-title":"Arch Fr Pediatr"},{"issue":"3","key":"10.1016\/j.ecl.2021.08.005_bib22","first-page":"239","article-title":"Nephrocalcinosis due to vitamin D intoxication","volume":"31","author":"Be\u015fba\u015f","year":"1989","journal-title":"Turk J Pediatr"},{"issue":"5","key":"10.1016\/j.ecl.2021.08.005_bib23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2105\/AJPH.85.5.656","article-title":"An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy","volume":"85","author":"Blank","year":"1995","journal-title":"Am J Public Health"},{"issue":"7","key":"10.1016\/j.ecl.2021.08.005_bib24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-122-7-199504010-00006","article-title":"Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity","volume":"122","author":"Pettifor","year":"1995","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ecl.2021.08.005_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0169-6009(90)90023-9","article-title":"The mechanisms of vitamin D toxicity","volume":"11","author":"Vieth","year":"1990","journal-title":"Bone Miner"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1172\/JCI109442","article-title":"Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis","volume":"64","author":"Bell","year":"1979","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.ecl.2021.08.005_bib27","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/jcem-60-5-960","article-title":"Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis","volume":"60","author":"Adams","year":"1985","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5768","key":"10.1016\/j.ecl.2021.08.005_bib28","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"issue":"38","key":"10.1016\/j.ecl.2021.08.005_bib29","first-page":"908","article-title":"[Chronic disorders of calcium and phosphate metabolism in children]","volume":"81","author":"FANCONI","year":"1951","journal-title":"Schweiz Med Wochenschr"},{"issue":"6779","key":"10.1016\/j.ecl.2021.08.005_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(53)90187-1","article-title":"Idiopathic hypercalcaemia in infants","volume":"265","author":"LIGHTWOOD","year":"1953","journal-title":"Lancet"},{"issue":"6929","key":"10.1016\/j.ecl.2021.08.005_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0140-6736(56)91518-5","article-title":"Metabolic studies on two infants with idiopathic hypercalcaemia","volume":"270","author":"Morgan","year":"1956","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib32","first-page":"190","article-title":"[Significance of metabolic disorders in the genesis of marasmus]","volume":"10","author":"Lightwood","year":"1953","journal-title":"Arch Fr Pediatr"},{"issue":"6","key":"10.1016\/j.ecl.2021.08.005_bib33","first-page":"1050","article-title":"The relation between infantile hypercalcemia and vitamin D--public health implications in North America","volume":"40","author":"Fraser","year":"1967","journal-title":"Pediatrics"},{"key":"10.1016\/j.ecl.2021.08.005_bib34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.24.6.1311","article-title":"Supravalvular aortic stenosis","volume":"24","author":"Williams","year":"1961","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2021.08.005_bib35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/01.CIR.26.6.1235","article-title":"Supravalvular aortic stenosis in association with mental retardation and a certain facial appearance","volume":"26","author":"Beuren","year":"1962","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0092-8674(93)90168-P","article-title":"The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis","volume":"73","author":"Curran","year":"1993","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.ecl.2021.08.005_bib37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM198504113121503","article-title":"Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies","volume":"312","author":"Garabedian","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ecl.2021.08.005_bib38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0092-8674(03)00436-7","article-title":"The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome","volume":"113","author":"Kitagawa","year":"2003","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s004670050221","article-title":"Persistent hypercalciuria and elevated 25-hydroxyvitamin D3 in children with infantile hypercalcaemia","volume":"11","author":"Pronicka","year":"1997","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1016\/j.ecl.2021.08.005_bib40","first-page":"431","article-title":"[Hypercalcemia following prophylactic vitamin D administration]","volume":"54","author":"Misselwitz","year":"1986","journal-title":"Kinderarztl Prax"},{"issue":"3","key":"10.1016\/j.ecl.2021.08.005_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0306-9877(79)90019-7","article-title":"Infantile hypercalcemia: a defect in the esterification of 1,25-dihydroxyvitamin D?","volume":"5","author":"Weisman","year":"1979","journal-title":"Med Hypotheses"},{"issue":"8","key":"10.1016\/j.ecl.2021.08.005_bib42","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s004670050678","article-title":"Familial occurrence of idiopathic infantile hypercalcemia","volume":"13","author":"McTaggart","year":"1999","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.ecl.2021.08.005_bib43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"365","author":"Schlingmann","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib44","doi-asserted-by":"crossref","first-page":"E268","DOI":"10.1210\/jc.2011-1972","article-title":"Genetic Defect in CYP24A1, the Vitamin D 24-Hydroxylase Gene, in a Patient with Severe Infantile Hypercalcemia","volume":"97","author":"Dauber","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib45","first-page":"552","article-title":"Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis","volume":"190","author":"Dinour","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ecl.2021.08.005_bib46","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jpeds.2013.04.056","article-title":"Lightwood syndrome revisited with a novel mutation in CYP24 and vitamin D supplement recommendations","volume":"163","author":"Castanet","year":"2013","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00431-012-1818-1","article-title":"Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene","volume":"172","author":"Fencl","year":"2013","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib48","first-page":"160","article-title":"Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia","volume":"7","author":"Skalova","year":"2013","journal-title":"Iran J Kidney Dis"},{"issue":"3","key":"10.1016\/j.ecl.2021.08.005_bib49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ndt\/gft460","article-title":"Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure","volume":"29","author":"Colussi","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.ajkd.2014.06.037","article-title":"Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations","volume":"65","author":"Figueres","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ecl.2021.08.005_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bone.2015.06.018","article-title":"Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study","volume":"81","author":"Cools","year":"2015","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00467-014-2889-1","article-title":"Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake","volume":"30","author":"Dinour","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1016\/j.ecl.2021.08.005_bib53","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2015-1973","article-title":"Maternal Hypercalcemia Due to Failure of 1,25-Dihydroxyvitamin-D3 Catabolism in a Patient With CYP24A1 Mutations","volume":"100","author":"Shah","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/js.2018-00337","article-title":"Three Sisters With Heterozygous Gene Variants of","volume":"3","author":"Hedberg","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"issue":"3","key":"10.1016\/j.ecl.2021.08.005_bib55","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1210\/clinem\/dgaa876","article-title":"Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?","volume":"106","author":"Brancatella","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2021.08.005_bib56","doi-asserted-by":"crossref","first-page":"E1343","DOI":"10.1210\/jc.2014-4387","article-title":"CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait","volume":"100","author":"Molin","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib57","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00424-018-2246-5","article-title":"Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: mutations and disease associations","volume":"471","author":"Lederer","year":"2019","journal-title":"Pflugers Arch"},{"issue":"9","key":"10.1016\/j.ecl.2021.08.005_bib59","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","article-title":"Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease","volume":"318","author":"Quarles","year":"2012","journal-title":"Exp Cell Res"},{"issue":"11","key":"10.1016\/j.ecl.2021.08.005_bib60","doi-asserted-by":"crossref","first-page":"E2451","DOI":"10.1210\/jc.2014-1517","article-title":"Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis","volume":"99","author":"Rajagopal","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2021.08.005_bib61","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1056\/NEJMoa0905647","article-title":"A\u00a0loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome","volume":"362","author":"Magen","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ecl.2021.08.005_bib62","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00467-018-3998-z","article-title":"Prenatal hyperechogenic kidneys in three cases of infantile hypercalcemia associated with SLC34A1 mutations","volume":"33","author":"Hureaux","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.ecl.2021.08.005_bib63","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13353-017-0397-2","article-title":"Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases","volume":"58","author":"Pronicka","year":"2017","journal-title":"J\u00a0Appl Genet"},{"issue":"12","key":"10.1016\/j.ecl.2021.08.005_bib64","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1210\/jc.2017-01592","article-title":"Clinical Heterogeneity and Phenotypic Expansion of NaPi-IIa-Associated Disease","volume":"102","author":"Demir","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2021.08.005_bib65","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1681\/ASN.2014040388","article-title":"Fourteen Monogenic Genes Account for 15% of Nephrolithiasis\/Nephrocalcinosis","volume":"26","author":"Halbritter","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ecl.2021.08.005_bib66","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2215\/CJN.07540715","article-title":"Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis","volume":"11","author":"Braun","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ecl.2021.08.005_bib67","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.kint.2017.06.025","article-title":"Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis","volume":"93","author":"Daga","year":"2018","journal-title":"Kidney Int"},{"issue":"13","key":"10.1016\/j.ecl.2021.08.005_bib68","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","article-title":"Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter","volume":"347","author":"Prie","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ecl.2021.08.005_bib69","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00467-016-3443-0","article-title":"Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency","volume":"31","author":"Dinour","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1016\/j.ecl.2021.08.005_bib70","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/ndt\/gfaa178","article-title":"Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations","volume":"36","author":"Janiec","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/499409","article-title":"SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis","volume":"78","author":"Bergwitz","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3","volume":"78","author":"Lorenz-Depiereux","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.ecl.2021.08.005_bib73","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1681\/ASN.2013101085","article-title":"Mutations in SLC34A3\/NPT2c are associated with kidney stones and nephrocalcinosis","volume":"25","author":"Dasgupta","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ecl.2021.08.005_bib74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7326\/0003-4819-149-4-200808190-00007","article-title":"Narrative review: furosemide for hypercalcemia: an unproven yet common practice","volume":"149","author":"LeGrand","year":"2008","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ecl.2021.08.005_bib75","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1440-1754.1996.tb02569.x","article-title":"Prednisolone and cellulose phosphate treatment in idiopathic infantile hypercalcaemia with nephrocalcinosis","volume":"32","author":"Mizusawa","year":"1996","journal-title":"J\u00a0Paediatr Child Health"},{"issue":"8\u20139 Pt 1","key":"10.1016\/j.ecl.2021.08.005_bib76","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/j.1552-4604.1979.tb02507.x","article-title":"Clinical pharmacology of sodium cellulose phosphate","volume":"19","author":"Pak","year":"1979","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.ecl.2021.08.005_bib77","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00467-006-0217-0","article-title":"Long-term follow-up of patients with idiopathic infantile hypercalcaemia","volume":"21","author":"Huang","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"3\u20134","key":"10.1016\/j.ecl.2021.08.005_bib78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/10606820213681","article-title":"Molecular pharmacology of the calcitonin receptor","volume":"8","author":"Purdue","year":"2002","journal-title":"Receptors Channels"},{"issue":"2","key":"10.1016\/j.ecl.2021.08.005_bib79","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpeds.2010.02.025","article-title":"Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment","volume":"157","author":"Nguyen","year":"2010","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.ecl.2021.08.005_bib80","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1210\/jcem-70-4-1090","article-title":"Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia","volume":"70","author":"Adams","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2021.08.005_bib81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2215\/CJN.05360512","article-title":"1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis","volume":"8","author":"Nesterova","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ecl.2021.08.005_bib82","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1210\/jc.2011-1935","article-title":"Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy","volume":"97","author":"Tebben","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabr"},{"issue":"4","key":"10.1016\/j.ecl.2021.08.005_bib83","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/ckj\/sfv028","article-title":"Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole","volume":"8","author":"Sayers","year":"2015","journal-title":"Clin Kidney J"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:23Z","timestamp":1760176043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852921000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0889852921000815"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2021.08.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D\u2013dependent Hypercalcemia","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2021.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}